Nepal earthquake: At least 66 killed, including 17 in India; over 1100 injured

May 12, 2015

Kathmandu, May 13: A powerful earthquake jolted mountainous Nepal on Tuesday, killing at least 66 people, including 17 in India and one in Chinese Tibet, bringing down buildings and triggering landslide less than three weeks after a devastating temblor left a swathe of destruction in the Himalayan nation.

nepal1

Hundreds of terrified people rushed out of their homes and buildings toppled as the 7.3-magnitude earthquake, centred 68km west of the town of Namche Bazaar near Mount Everest, sent ripples in India all the way from the border states of Bihar and West Bengal to Gujarat and Delhi.

In Nepal the death toll reached 48, with 1,176 injured, police spokesperson Kamal Singh Bam said.

Seventeen people were killed in Bihar and Uttar Pradesh, the home ministry said in a statement, and Chinese media reported one person died in Tibet after rocks fell on a car.

"I was taking my afternoon nap after lunch and somehow managed to rush out with my baby. My house is safe but I am afraid to go inside," said Bimala Magar, a resident of Kathmandu's Dhumbarahi.

More than 1,000 people were injured as the quake flattened buildings in Kathmandu and other parts of Nepal already weakened by the 7.9-magnitude April 25 earthquake.

The fresh tremors, which lasted nearly a minute, came just as residents of Kathmandu and other districts were picking up the pieces after last month's quake that killed about 8,000 people and uprooted millions.

Rescue helicopters were sent to districts northeast of Kathmandu, where landslides and buildings, collapsed by Tuesday's quake, may have left people buried, the government said. Home ministry spokesperson Laxmi Dhakal named Sindhupalchok and Dolkha districts as the hardest hit.

Many people were still seen grouped together on roads and open spaces more than three hours after the quake which was followed by at least eight powerful aftershocks.

nepal2

Parents were seen clutching children tightly and hundreds frantically tried to call relatives on their mobile phones. Shopkeepers closed their shops and the streets were jammed with people rushing to check on their families.

Nepal Police sent out tweets asking residents to clear the roads for movement of rescue workers while police also asked people not to clog the mobile network with calls and use text messages for sending information.

Operations at Kathmandu's Tribuvan International Airport were suspended and Nepal's parliament, which was in session when the quake struck, was also adjourned.

"Search and rescue teams have been sent to all affected districts. These are difficult times for Nepal, I appeal for all friends to help us and urge our citizens to stay strong," Prime Minister Sushil Koirala said.

Mountaineers seeking to scale the world's tallest peak have called off this year's Everest season after 18 people died when last month's quake triggered avalanches.

Dambar Parajuli, president of Expedition Operators' Association of Nepal, said there were no climbers or sherpa guides at the Base Camp when the quake struck on Tuesday. "All of them have already left," Parajuli said.

In Lukla, the departure point for treks to Everest, buildings cracked and small landslides were triggered when the ground shook.

"We saw the mountain in front of us fall down ... earth and rocks,” said Susana Perez from Madrid, who was on a 10-day trek with her husband to Island Peak in the Everest region and was about to reach Lukla. “There were some houses underneath but it was not clear if they were hit."

Earthquake: 42 killed in Nepal, 17 in India

Kathmandu, May 12: A new 7.3-magnitude earthquake and several powerful aftershocks shook Nepal today killing at least 42 people and triggering panic in the Himalayan nation already devastated by a massive temblor less than three weeks back that had claimed over 8,000 lives.

Nepal's Home Ministry while putting the death toll at 42 said another 1,117 people had been injured in the latest quake that hit hardest in remote mountain districts northeast of the country's capital Kathmandu.

The earthquake struck at 12:35 PM, some 83 km east of Kathmandu near Mount Everest at a shallow depth of 15 km, the US Geological Survey(USGS) said.

The agency had earlier measured the quake at 7.4 on the Richter Scale but later revised the intensity to 7.3.

The quake hit Dolakha and Sindhupalchowk districts - the worst-affected areas in the last month's temblor. At least 19 people were killed in Dolakha, police said.

A second tremor of 6.3-magnitude struck about 30 minutes after the 7.3-magnitude quake that sent terrifed residents running into the streets of the traumatised capital.
The USGS said there were five more aftershocks measuring over 5 on the Richter Scale after the second tremor that kept people on the edge.

Police said half-a-dozen buildings were destroyed in Kathmandu.

The fresh quake triggered massive panic among the people, who have been staying in the open since the 7.9-magnitude temblor struck on April 25, killing over 8,000 people and flattening thousands of buildings besides destroying whole villages.

"All available helicopters along with Medical Team; SSR Team going to be mobilised to Dolakha and Sindhupalchowk soon," said Nepal's National Emergency Operation Centre.

The Indian Air Force (IAF) has stationed eight helicopters in Nepal and one of them conducted an aerial survey soon after today's quake.

Nepal's only international airport, the Tribhuvan International Airport, was briefly closed by authorities and flights to Kathmandu were diverted.

Authorities have also ordered all schools to be closed for the next two weeks.

Strong tremors were felt in Kathmandu where people ran out of their houses in panic and some even started crying. Authorities appealed to people to stay in open field.

The temblor triggered landslides and toppled buildings in Nepal that recently witnessed its worst quake in over 80 years and over 160 aftershocks.

At the main hospital in Kathmandu, patients hurt in last month's quake were brought out in wheelchairs to avoid further injury.

Today's quake had its impact in several cities in Bihar, West Bengal and UP and tremors were felt across vast stretches of east and northeast India, where the death toll has reached 17 so far.

The tremors were also felt in China, where one woman was killed in Tibet.

quake jolts Nepal

Nepal quake 1

Nepal quake 1

Nepal quake 1

Nepal quake 1

Nepal quake 1

Nepal quake 1

Nepal quake 1

Nepal quake 1

Nepal quake 1

Nepal quake 1

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 17,2020

Washington, May 17: The overall number of global coronavirus cases has increased to over 4.6 million, while the death toll has surpassed 311,000, according to the Johns Hopkins University.

As of Sunday morning, the total number of cases stood at 4,634,068, while the death toll increased to 311,781, the University's Center for Systems Science and Engineering (CSSE) revealed in its latest update.

The US currently accounts for the world's highest number of cases and deaths at 1,467,796 and 88,754, respectively.

In terms of cases, Russia has the second highest number of infections at 272,043, followed by the UK (241,461), Brazil (233,142), Spain (230,698), Italy (224,760), France (179,630), Germany (175,752), Turkey (148,067) and Iran (118,392), the CSSE figures showed.

Meanwhile, the UK accounted for the second highest COVID-19 deaths worldwide at 34,546.

The other countries with over 10,000 deaths are Italy (31,763), Spain (27,563), France (27,532), and Brazil (15,662).

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agecnies
July 13,2020

Moscow, Jul 13: Russia has become the first nation to complete clinical trials of a COVID-19 vaccine on humans. Chief researcher Elena Smolyarchuk, who heads the Center for Clinical Research on Medications at Sechenov University, told Russian news agency TASS on Sunday that the human trials for the vaccine have been completed at the university and the volunteers will be discharged soon.

"The research has been completed and it proved that the vaccine is safe. The volunteers will be discharged on July 15 and July 20," Smolyarchuk was quoted as saying in the report.

Though the results have been favourable with respect to the medication’s effectiveness, no further information was provided on when this vaccine would enter commercial production stage.

Russia had allowed clinical trials of two forms of a potential COVID-19 vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology on June 18.

The first vaccine, in the form of a solution for intramuscular administration, was carried out at the Burdenko Military Hospital.

Another vaccine, in the form of a powder for the preparation of a solution for intramuscular administration, was carried out at Sechenov First Moscow State Medical University.

The first stage of research on the vaccine at Sechenov University involved a group of 18 volunteers and the second group involved 20 volunteers.

After vaccination, all volunteers were expected to remain in isolation in a hospital for 28 days.

Earlier, results of the COVID-19 vaccine tests performed on a group of volunteers in Russia showed that they were developing immunity to the coronavirus.

"The data obtained by the Gamalei National Research Center for Epidemiology and Microbiology, proves that volunteers of the first and second groups are forming an immune response after injections of the vaccine against the coronavirus," according to an earlier statement from the Russian Defense Ministry.

Russia has reported 719,449 cases and 11,188 deaths to date.

There are at least 21 vaccines currently under key trials, according to the World Health Organisation (WHO).

The overall number of global COVID-19 cases crossed 12.9 million, while the deaths have increased to more than 5,69,000, according to Johns Hopkins University in the US.

As of Monday morning, the total number of cases stood at 1,29,10,357, while the fatalities rose to 5,69,128.

The US accounted for the world's highest number of infections at over 33 lakh. Brazil came in the second place with over 18 lakh infections. India is third worst affected with over 8.7 lakh people reported to have COVID-19.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 19,2020

May 19: A Chinese laboratory has been developing a drug it believes has the power to bring the coronavirus pandemic to a halt.

The outbreak first emerged in China late last year before spreading across the world, prompting an international race to find treatments and vaccines.

A drug being tested by scientists at China's prestigious Peking University could not only shorten the recovery time for those infected, but even offer short-term immunity from the virus, researchers say.

Sunney Xie, director of the university's Beijing Advanced Innovation Center for Genomics, told AFP that the drug has been successful at the animal testing stage.

"When we injected neutralising antibodies into infected mice, after five days the viral load was reduced by a factor of 2,500," said Xie.

"That means this potential drug has (a) therapeutic effect."

The drug uses neutralising antibodies -- produced by the human immune system to prevent the virus infecting cells -- which Xie's team isolated from the blood of 60 recovered patients.

A study on the team's research, published Sunday in the scientific journal Cell, suggests that using the antibodies provides a potential "cure" for the disease and shortens recovery time.

Xie said his team had been working "day and night" searching for the antibody.

"Our expertise is single-cell genomics rather than immunology or virology. When we realised that the single-cell genomic approach can effectively find the neutralising antibody we were thrilled."

He added that the drug should be ready for use later this year and in time for any potential winter outbreak of the virus, which has infected 4.8 million people around the world and killed more than 315,000.

"Planning for the clinical trial is underway," said Xie, adding it will be carried out in Australia and other countries since cases have dwindled in China, offering fewer human guinea pigs for testing.

"The hope is these neutralised antibodies can become a specialised drug that would stop the pandemic," he said.

China already has five potential coronavirus vaccines at the human trial stage, a health official said last week.

But the World Health Organization has warned that developing a vaccine could take 12 to 18 months.

Scientists have also pointed to the potential benefits of plasma -- a blood fluid -- from recovered individuals who have developed antibodies to the virus enabling the body's defences to attack it.

More than 700 patients have received plasma therapy in China, a process which authorities said showed "very good therapeutic effects".

"However, it (plasma) is limited in supply," Xie said, noting that the 14 neutralising antibodies used in their drug could be put into mass production quickly.

Using antibodies in drug treatments is not a new approach, and it has been successful in treating several other viruses such as HIV, Ebola and Middle East Respiratory Syndrome (MERS).

Xie said his researchers had "an early start" since the outbreak started in China before spreading to other countries.

Ebola drug Remdesivir was considered a hopeful early treatment for COVID-19 -- clinical trials in the US showed it shortened the recovery time in some patients by a third -- but the difference in mortality rate was not significant.

The new drug could even offer short-term protection against the virus.

The study showed that if the neutralising antibody was injected before the mice were infected with the virus, the mice stayed free of infection and no virus was detected.

This may offer temporary protection for medical workers for a few weeks, which Xie said they are hoping to "extend to a few months".

More than 100 vaccines for COVID-19 are in the works globally, but as the process of vaccine development is more demanding, Xie is hoping that the new drug could be a faster and more efficient way to stop the global march of the coronavirus.

"We would be able to stop the pandemic with an effective drug, even without a vaccine," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.